Moderna is a biotechnology company that gained significant recognition during the COVID-19 pandemic for developing one of the first mRNA-based vaccines. Established in 2010, Moderna focuses on the development of mRNA-based therapies and vaccines to treat a variety of diseases, including infectious diseases, cardiovascular conditions, and cancer.
